UBS Group »

Theriva Biologics shares owned by UBS Group

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.3k 23k 0.41
2025-06-30 $0 1 0.00
2025-03-31 $8.7k 7.9k 1.11
2024-12-31 $29k 16k 1.75
2024-09-30 $25k 18k 1.38